The title and the abstract form the gateway to a study, and a well-defined combination rolls out the red carpet for the audience. The ability to write a good abstract is therefore an important skill, ...

MILWAUKEE, Oct. 30, 2025 /PRNewswire/ -- The Society for Immunotherapy of Cancer (SITC) received an incredible number of abstract submissions in 2025, more than 1,300, including many clinical based ...

The brevity of an abstract belies its importance to a manuscript. It’s what catches a reader’s attention and helps them to decide whether a paper is relevant. Yet failing to reflect the content of the ...

Real-world data from 844,000 patient records highlight the power of remote therapeutic monitoring to improve outcomes and reduce risk in chronic pain care The abstract presents a retrospective cohort ...

These clinical abstracts are courtesy of the organization WeMove (Worldwide Education and Awareness for Movement Disorders). Learn more about this group at their Web site: www.wemove.org. WeMove ...

Nonsteroidal Anti-Inflammatory Drugs, Alone or Combined With Opioids, for Cancer Pain Brief description of the intervention, explicit identification of the primary end point, and presentation of ...

SOUTH SAN FRANCISCO, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. (ALXO),, an immuno-oncology company developing therapies that block the CD47 immune checkpoint pathway, today ...

CAMBRIDGE, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that preclinical and clinical data supporting the ...

UTRECHT, The Netherlands and CAMBRIDGE, Mass., July 28, 2023 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, ...

KRAKOW, Poland, May 12, 2021 /PRNewswire/ — Ryvu Therapeutics (WSE: RVU) today announced that three abstracts demonstrating clinical and pre-clinical activity of its selective CDK8/19 inhibitor RVU120 ...